Latest Information Update: 05 Apr 2011
At a glance
- Originator Allergan
- Class Glucans; Glycerides
- Mechanism of Action Androgen receptor modulators; Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Dry eyes
Most Recent Events
- 05 Apr 2011 Development discontinued for Dry eyes before April 2011
- 28 Apr 2008 Phase-II clinical trials in Dry eyes in USA (Intraocular)